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Olive Oil Phenolics Prevent Oxysterol-Induced
Proinﬂammatory Cytokine Secretion and Reactive
Oxygen Species Production in Human Peripheral
Blood Mononuclear Cells, Through Modulation
of p38 and JNK Pathways
Gessica Serra,* Monica Deiana, Jeremy P. E. Spencer, and Giulia Corona
Scope: The aim of the present study was to investigate the ability of extra
virgin olive oil (EVOO) polyphenols to counteract the proinﬂammatory eﬀects
induced by dietary and endogenous oxysterols in ex vivo immune cells.
Methods and results: Peripheral blood mononuclear cells (PBMCs),
separated from the whole blood of healthy donors, were utilized and were
stimulated with an oxysterols mixture, in the presence of physiologically
relevant concentrations of the EVOO polyphenols, hydroxytyrosol, tyrosol,
and homovanillic alcohol. Oxysterols signiﬁcantly increased the production of
proinﬂammatory cytokines, interleukin-1β, regulated on activation, normal
T-cell expressed and secreted and macrophage migration inhibitory factor in
ex vivo cultured PBMCs. Increased levels of reactive oxygen species (ROS)
were also detected along with increased phosphorylation of the p38 and JNK.
All phenolic compounds signiﬁcantly reduced cytokine secretion induced by
the oxysterols and inhibited ROS production and mitogen activated protein
kinase phosphorylation.
Conclusions: These results suggest that extra virgin olive oil polyphenols
modulate the immune response induced by dietary and endogenous
cholesterol oxidation products in human immune cells and may hold beneﬁt
in controlling chronic immune and/or inﬂammatory processes.
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1. Introduction
Oxysterols are 27-carbon-atommolecules
resulting from nonenzymatic or enzy-
matic oxidation of cholesterol and have
been detected in plasma and tissues due
to endogenous formation and dietary
intake.[1–3] High levels of oxysterols, gen-
erated by dysfunction in endogenous pro-
duction or through high dietary intake,
can aﬀect cellular metabolism, change
membrane composition/property, and
promote the onset and progression of
major chronic and degenerative diseases
such as cancer and atherosclerosis.[4,5]
It is thought that such deleterious ef-
fects are due to their ability to trigger
cytotoxic, prooxidative, and proinﬂam-
matory reactions,[6] such as the produc-
tion of superoxide anions (O−2) and re-
active oxygen species (ROS), or through
their potential to enhance proinﬂamma-
tory cytokine expression and secretion
levels (tumor necrosis factor-α (TNF-α),
IL-1β, IL-6, IL-8, monocyte inﬂammatory
protein-1 (MIP-1β), cellular adhesion molecule-1 (ICAM-1), vas-
cular cell adhesion molecule-1 (VCAM-1) and E-selectin.[7] No-
tably, the expression of these and other inﬂammatory me-
diators is closely dependent on the activity nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-κb), through
activation of the mitogen-activated protein kinase (MAPK)
pathways.[8]
Extra virgin olive oil, the main fat source in the Mediterranean
diet, with its high content inmonounsaturated fatty acids and rel-
atively high polyphenol content, may attenuate such inﬂamma-
tory responses and exert beneﬁcial eﬀects in modulating chronic
low-grade inﬂammation.[9–13] Extra virgin olive oil (EVOO) and
its bioactive minor components, in particular, oleuropein,[14,15]
hydroxytyrosol,[16–21] and oleocanthal,[22,23] but also the entire phe-
nolic fraction,[24,25] have been largely investigated in in vitro
models and many ﬁndings support their anti-inﬂammatory and
immune-modulatory eﬀects.
This is thought to occur through their capacity to limit
the ROS and nitrogen species formation[16,24–28] and to inhibit
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the proinﬂammatory activity of ROS-generating enzymes in-
cluding cyclooxygenase-2 (COX-2),[18,24,25,27,28] inducible nitric
oxide synthase (iNOS)[18,20,24,25,28,29] and to modulate diﬀerent
intracellular signaling pathways from nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-κB) to MAPK
through perturbation of redox-sensible networks in immune
cells.[26]
Also many in vivo studies have suggested that EVOO with
high phenolic concentration is eﬀective inmodulating inﬂamma-
tory mediator derived from arachidonic acid, such as TBX2 and
LTB4[30–33] as well as other inﬂammatory markers, such as high-
sensitivity C-reactive protein,[13,34] IL-6,[10,34,35] IL-β,[36] IFN-λ, and
IL-7,[30,37] VCAM-1, ICAM-1, TNF-α, and monocyte chemoattrac-
tant protein-1.[10]
The aim of this study was to investigate the ability of dif-
ferent olive oil pure phenolic compounds, (HT, TYR (tyrosol),
and HVA), found in the blood after ingestion and absorption of
EVOO, to prevent inﬂammatory eﬀects induced by oxysterols in
human immune cells, and to understand the implicated mecha-
nism of action.
Peripheral blood mononuclear cells (PBMCs), separated from
whole blood of healthy donors, were used for this purpose;
these cells are a good model to study the inﬂammatory re-
sponses ex vivo since they are composed by lymphocytes, mono-
cytes, and macrophages, critical components in the immune
system to ﬁght inﬂammation and source of proinﬂammatory
molecules.
PBMCs were treated with an oxysterols mixture composed
by the most widely represented oxysterols in plasma of hy-
percholesterolemic subjects: 7α-hydroxycholesterol (7α-HC),
7β-hydroxycholesterol (7β-HC), 7-ketocholesterol (7-KC),
cholesterol 5α,6α-epoxide (5α,6α-EC), cholesterol 5β,6β-
epoxide (5β,6β-EC), cholestane-3β,5α,6β-triol (triol), and
25-hydroxycholesterol (25-HC)[38] at pathologically relevant
concentration (20 μM). PBMCs were used in order to investigate
the ability of the olive oil simple phenols to inhibit the increase
of ROS and proinﬂammatory cytokine/chemokine synthesis
(IL-1β, MIF (macrophage migration inhibitory factor), and
RANTES (regulated on activation, normal T-cell expressed
and secreted)) induced by the oxysterols mixture, and to
modulate the signaling pathways (MAPK) involved in these
processes.
2. Experimental Section
2.1. Reagents
Media and supplements were purchased from Lonza (Slough,
UK). Histopaque-1077, oxysterols, 2′,7′-dichloroﬂuorescein diac-
etate (DCFH-DA), horseradish peroxidase-conjugated goat anti-
rabbit secondary antibody, Bradford reagent, and solvents were
purchased from Sigma Aldrich (Poole, UK). The cytokine kits
were purchased from R&D systems (Abingdon, UK). Gels and all
material for electrophoresis and immunoblotting were obtained
from Invitrogen (Milan, Italy). The Western Blotting System was
from Bio-Rad (Milan, Italy). The primary antibodies were pur-
chased from Millipore (Watford, UK).
2.2. Isolation and Culture of Human Peripheral Blood
Mononuclear Cells
The study was approved by the Ethics and Research Committee
of the University of Reading (Project No. 12/16) and informed
consent obtained from each blood donor.
The volunteers (males and females, aged between 23 and
40 years) were enrolled according to speciﬁc inclusion (signed
informed consent, men, and women aged 20–40 years, non-
smokers, good general health) and exclusion criteria (history of
drug abuse, including alcohol, participation in experimental tri-
als within 3 months prior to study, use of antibiotics within
the previous 3 months, use of prescribed medication, regular
use of anti-inﬂammatory drugs, any kind of inﬂammatory, auto-
immune disease or allergy, any other pathology).
Overnight fasting (12 hours) venous blood samples from 14
healthy donors were collected in the morning in sodium-heparin
coated tubes (Greiner Bio-One Limited, Gloucestershire, UK).
PBMCs were immediately isolated by a Ficoll-Hypaque
(Histopaque-1077) density gradient from 5 ml of whole pe-
ripheral blood following the manufacturer instructions and re-
suspended in the culture medium consisting of RPMI 1640, 1%
v/v glutamine and 1% v/v antibiotics, supplemented with autol-
ogous plasma (2.5% v/v). PBMCs were counted and cultured at
37°C in a 5% CO2 humidiﬁed atmosphere.
2.3. Cell Treatments for Cytokines Analysis
PBMCs (1 × 106 cells/mL) were seeded in 24-well plate in com-
plete RPMI, pretreated or not with HT, TYR, and homovanillic
alcohol (HVA) (0.25, 0.5, 1μM) and incubated for 30 min at 37°C
in a 5% CO2 atmosphere. Then, the oxysterols mixture, 20 μM
in ethanol, was added in the medium for 24 h.
An equivalent amount of ethanol was added to the control cells
for all the treatments.
At the end of the incubation period well contents were re-
moved, transferred to eppendorf tubes and centrifuged to pellet
the cells at 400 × g for 5 min at 20°C. The supernatants were
collected in clean tubes and stored at –20°C until analysis. The
percentage composition of the oxysterols mixture used was: 7α-
HC (5%), 7β-HC (10%), 5α,6α-EC (20%), 5β,6β-EC (20%), triol
(9%), 7-KC (35%), and 25-HC (1%).
2.4. Measurement of Cytokine/Chemokines Production
Cytokines were preliminarily measured in cell culture super-
natants (400 μL) of two samples, control and treated with the
oxysterols mixture, 20 μM in ethanol, by a semi-quantitative
method to simultaneously detect the relative levels of 36 diﬀer-
ent cytokines and chemokines using the Human Cytokine Array
Panel A (R&D systems, Abingdon, UK) following the manufac-
turer instructions. The membranes were developed using Im-
ageQuant LAS 4000 mini. Signal intensities of each membrane
array were analyzed using the ImageQuant software (Molecu-
lar Dynamics, Amersham Pharmacia Biotech). Three cytokines
were selected for quantitative analysis by ELISA on the basis
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of the initial screening process described earlier. Levels of hu-
man cytokines IL-1β, MIF, and RANTES were quantiﬁed using
appropriate kits (“Human IL-1β/IL-1F2 DuoSet,” “Human MIF
DuoSet,” and “Human CCL5/RANTES DuoSet” R&D systems,
Abingdon, UK), following the manufacturer’s instructions.
2.5. Measurement of Intracellular ROS Production
Intracellular ROS production was measured using the probe
DCFH-DA.
PBMCs (1× 106 cells/mL) were seeded in 24-well plate in com-
plete RPMI. In the ﬁrst set of experiments cells were incubated
for 30 min with DCFH-DA 10 μM in the dark at 37°C. DCFH-
DA was then removed, and cells were washed with PBS and in-
cubated with the oxysterols mixture, 20 μM in ethanol, added in
fresh medium. DCFH-DA loaded cells were immediately placed
in a plate reader (Plate reader, Inﬁnite 200, GENios TECAN) set-
ting the excitation ﬁlter at 485 nm and the emission ﬁlter at
530 nm, with temperature maintained at 37°C. ROS production
was monitored by reading the ﬂuorescence emitted taking read-
ings at intervals of 30 min for 3 h. In the second set of exper-
iments cells were pre-treated or not with pure phenolic com-
pounds, HT, TYR, and HVA (0.25, 0.5, 1 μM) and incubated for
30min at 37°C in a 5%CO2 atmosphere. Cells were then washed,
treated with DCFH-DA 10 μM and incubated for 30 min in the
dark at 37°C. DCFH-DA was then removed; cells were washed
and incubated with the oxysterols mixture 20 μM added in fresh
medium for 2 h. The ﬂuorescence emitted from the cells was
measured with the same method for 2 h.
2.6. Isolation of Proteins and Western Blot Analysis of JNK 1/2
and p38
PBMCs (5 × 106 cells/mL) were seeded in 6-well plate in com-
plete RPMI, pretreated or not with HT, TYR, and HVA (0.25,
0.5, 1 μM) and incubated for 30 min at 37°C in a 5% CO2 at-
mosphere. The oxysterols mixture, 20 μM in ethanol, was then
added in the medium and cells incubated for 3 h. Well contents
were collected and centrifuged at 400 × g for 5 min at 4°C. Su-
pernatants were discarded and cells washed/centrifuged twice
with cold PBS. Finally, the pellets were suspended with 150 μL
of complete lysis buﬀer (Cell Lytic M, Sigma) with protease and
phosphatase inhibitors (COmplete Ultra tablets and Mini, Phos-
phoSTOP, Roche) and incubated on ice for 30 min (by vortexing
every 10 min). At the end, lysates were centrifuged at 15 000 × g
for 5 min at 4°C to remove any particles or cell debris and the su-
pernatants were collected for protein analysis. The protein con-
centration was determined by the Bradford protein assay,[39] and
20μg of protein sample were subjected to SDS-page and western
immunoblotting as previously described.[40] The antibodies used
were anti-pp38 (1:1000 dilution), anti-p38 (1/1000 dilution), anti-
pJNK 1/2 (1:200 dilution), anti-JNK 1/2 (1:200 dilution), and goat
anti-rabbit IgG conjugated to horseradish peroxidase (1:2000 di-
lution). The blots were exposed to Hyperﬁlm-ECL and developed
with the ChemiDoc XRS Imager (BioRad). Protein bands were
quantiﬁed using Image J software.
2.7. Statistical Analysis
The statistical signiﬁcance of results was evaluated by one-way
ANOVA followed by Bonferroni’s multiple comparison posttest
using GraphPad Prism V5 (GraphPad Software, San Diego, CA,
USA). p Values of <0.05 were considered statistically signiﬁcant.
3. Results
3.1. Eﬀect of Olive Oil Phenolics on Oxysterol-Induced Cytokine
Secretion
After an initial screening with 36 cytokines with a human cy-
tokine proteome proﬁler array, three cytokines that weremost sig-
niﬁcantlymodulated by oxysterols were selected for further study.
The levels of 3 selected cytokines (IL-1β, MIF, and RANTES)
were further subjected to quantitative analysis, which indicated
that a 24 h exposure of PBMCs to oxysterols (20 μM) resulted
in a signiﬁcant increase in the secretion of the proinﬂamma-
tory cytokines/chemokines, IL-1β (Figure 1A), MIF (Figure 1B)
and RANTES (Figure 1C) in PBMCs. Pretreatment with HT,
TYR, and HVA (0.25, 0.5, 1 μM), signiﬁcantly reduced the secre-
tion of proinﬂammatory cytokines/chemokines induced by the
oxysterols.
3.2. Olive Oil Phenolics Inhibit Oxysterol-Induced Intracellular
ROS Production
Oxysterols (20 μM) also signiﬁcantly increased intracellular ROS
production over a 180 min timeframe (Figure 2). Pretreatment
of PBMCs with HT, TYR, and HVA (0.25, 0.5, 1 μM) for
30 min prior to the addition of oxysterols led to a reduced in-
tracellular ROS production at concentrations of 0.5 and 1.0 μM
(Figure 3), with HT and TYR signiﬁcantly more active than
HVA.
3.3. Eﬀect of Olive Oil Phenolics on Redox-Sensitive Pathways
Involved in Oxysterol-Induced Cytokine Production
The oxysterol mixture induced an increase in the level of the
phosphorylated forms of JNK 1/2 (p-JNK 1/2) in PBMCs follow-
ing 3 h of exposure to PBMCs. All polyphenols were shown to
signiﬁcantly attenuate these increases with the exception ofHVA,
at 0.5 μM (Figure 4). Similarly, oxysterols also induced the phos-
phorylation of p38 in PBMCs, with all phenolic compounds coun-
teracting these eﬀects at the highest concentration and HT also
active at 0.25 μM (Figure 5).
4. Discussion
Cholesterol oxidation products, termed oxysterols, may either
originate endogenously, through enzymatic or nonenzymatic
reactions, or may derive from the diet. As regards exoge-
nous sources of oxysterols, foods containing cholesterol are
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Figure 1. Eﬀects of HT, TYR and HVA (0.25–0.5–1 μM) on the proinﬂam-
matory cytokines IL-1β (A), MIF (B), and RANTES (C) secretion in PBMCs
treated with the oxysterols mixture 20 μM for 24 h. Each column repre-
sents the mean ± SD of six independent experiments. *** = p < 0.001
versus Ctrl; a = p < 0.001, b = p < 0.01, c = p < 0.05 versus oxy. Control
value: IL-1β = 91 pg/mL, MIF = 770 pg/mL, RANTES = 2800 pg/mL.
susceptible to oxidation: oxidative reactions occur during food
processing, mainly on exposure to heat treatment and during
long-term storage.[41]
They are involved in physiological processes such as the reg-
ulation of cholesterol homeostasis, but it is well established that
oxysterols havemostly detrimental biological activities. They pro-
Figure 2. Intracellular ROS production (expressed as fold increase) in
PBMCs treated with the oxysterols mixture 20 μM for diﬀerent incubation
times (15–180 min) using the ﬂuorescence probe DFC-DA 10 μM for 30
min. Each column represents the mean ± SD of six independent experi-
ments. *** = p < 0.001 versus ctrl.
Figure 3. Eﬀect of HT, TYR, and HVA (0.25–0.5–1 μM) on intracellular
ROS production in PBMCs treated with the oxysterols mixture 20 μM for
2 h. Each column represents the mean ± SD of six independent experi-
ments. *** = p < 0.001 versus Ctrl; a = p < 0.001, b = p < 0.01, c = p <
0.05 versus Oxy.
voke an imbalance of the ratio between oxidative and reductive
biochemical reactions (oxidative stress) that acts on all organism
levels, from cell signaling to disease expression through upregu-
lation of inﬂammation, apoptosis, and ﬁbrosis.[7,42]
Pathological accumulation of oxysterols may contribute in
fact to the onset and especially to the development of major
chronic diseases in which inﬂammation, but also oxidative dam-
age and to a certain extent cell death, are hallmarks and primary
mechanisms of progression. Indeed, certain oxysterols exercise
strong prooxidant and proinﬂammatory eﬀects at concentrations
detectable in the lesions typical of atherosclerosis, neurodegen-
erative diseases, age-related macular degeneration, and other
pathological conditions characterized by altered cholesterol up-
take and/or metabolism.[6]
Several studies in animals and humans have shown that di-
etary oxysterols, after digestion can be absorbed from the gut
and transported into the circulation within chylomicrons and
other lipoproteins.[43,44] Furthermore, the presence of oxysterols
in plasma can derive from the oxidation of endogenous choles-
terol through enzymatic or spontaneous reactions.[7]
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Figure 4. Modulation of JNK 1/2 in PBMCs pretreated or not for 30 min
with HT, TYR, and HVA (0.25–1 μM) and incubated with the oxysterols
mixture 20 μM for 3 h. Each column represents the mean ± SD of three
independent experiments. *** = p < 0.001 versus Ctrl; a = p < 0.001 ver-
sus Oxy.
Figure 5. Modulation of p38 in PBMCs pretreated or not for 30 min with
HT, TYR, and HVA (0.25–1 μM) and incubated with the oxysterols mixture
20 μM for 3 h. Each column represents the mean ± SD of three indepen-
dent experiments. *** = p < 0.001 versus Ctrl; a= p < 0.001, c= p < 0.05
versus Oxy.
Oxysterols have been found at increased levels in the plasma
of hypercholesterolemic subjects and have been linked with the
atherosclerotic process.[45]
This study focused on the protective eﬀect of pure olive oil phe-
nolics, which can be found in the blood stream after absorption
(HT, TYR, and HVA) against the prooxidant and proinﬂamma-
tory activity of oxysterols in immune blood cells.
The phenolic compounds used in our study are
bioavailable,[46–49] as shown in numerous studies, and the
concentrations used in this study are physiologically relevant
(0.25–0.5–1 μM).[50]
PBMCs separated from whole blood of healthy volunteers
were used for this study; these are composed by lymphocytes,
monocytes and macrophages, critical components in the im-
mune system to ﬁght inﬂammation and source of proinﬂamma-
tory molecules.
PBMCs cells were treated with an oxysterols mixture com-
posed by the most widely represented oxysterols in plasma of
hypercholesterolemic subjects: 7α-HC, 7β-HC, 7-KC, 5α,6α-EC,
5β,6β-EC, triol, and 25-HC[38] at pathologically relevant concen-
tration (20 μM). In fact, oxysterols in human plasma or serum
may vary from about 1 μM (0.05% of total cholesterol) in healthy
subjects to 20–30 μM (0.5-0.75% of total cholesterol) in diseased
individuals, butmuch higher concentrations of plasma oxysterols
have also been reported.[4,45,51]
The ﬁrst intent was to examine the ability of PBMCs to pro-
duce cytokines and chemokines in the presence of oxysterols, in
particular, IL-1β, MIF, and RANTES, usually involved in proin-
ﬂammatory processes; the oxysterols mixture was able to signif-
icantly increase the secretion of all cytokines/chemokines ana-
lyzed. Since it has been suggested that oxysterols may increase
the levels of cytokines bymodulating redox-sensitive pathways,[52]
the oxidative status of PBMCs treated with the oxysterols mixture
was then measured. An early increase (after 15 min) of intracel-
lular ROS production was observed in PBMCs challenged with
oxysterols compared to control. Atmoderate concentrations, ROS
may act as second messengers in signal transduction, by mod-
ulating redox-sensitive MAPK; these kinases have been already
reported to be activated by various stress stimuli, including treat-
ments with diﬀerent oxysterols, 7-KC and 25-HC[52,53] and they
have been also implicated in oxysterol-induced cytokine secretion
and apoptosis.[6,52,54]
In the experimental conditions of this research, the oxys-
terols mixture induced a signiﬁcant increase of both JNK and
p38 phosphorylation suggesting their involvement in cytokine
secretion.
These results are in accordance with other experimental stud-
ies; for example, in human monocytic cells, 7β-HC and 25-HC,
but also 7-KC to a lesser extent, are potent in vitro inducers of
IL-1β, IL-8, TNF-α, and MIP-1β, as well as of other inﬂamma-
tory molecules.[55] The same study demonstrated that IL-8 se-
cretion was associated with activation of the ERK 1/2 signaling
pathway.[55] The oxysterols 7-KC and 25-HC have also been ob-
served to enhance IL-1β, IL-6, IL-8, and TNF-α mRNA and se-
cretion levels, in a dose-dependent manner, although to diﬀerent
extents. These eﬀects were associated with increased ROS pro-
duction, and a net phosphorylation ofMAPK (ERK 1/2, JNK, p38)
and NF-κB activation also occurred.[52]
Upregulation of IL-1β is another important event, because
this cytokine increases the surface expression of endothelial ad-
hesion molecules, by facilitating inﬂammatory cells attachment
to the artery endothelium. Expression and synthesis of IL-1β
were found to be stimulated by 25-HC in human macrophages,
through the involvement of the liver X receptor, as well as, but
less strongly, by 27-hydroxycholesterol.[56] IL-1β secretion was
also markedly induced by 7β-HC, 7-KC, and 7α-HC in human
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promonocytic cells U937 and U4[57,58] and in human umbilical
vein endothelial cells (HUVECs).[59] Production of the proinﬂam-
matory cytokines TNF-α and IL-1β is also induced by 25-HC
in adherent human peripheral blood mononuclear leukocytes,
through phosphorylation of p38 MAPK.[60] In the literature there
is not any speciﬁc correlation between oxysterols and RANTES
and MIF secretion; but the increased RANTES and MIF expres-
sions have been associated with a wide range of inﬂammatory
disorders and pathologies, such as inﬂammatory bowel disease
and atherosclerosis where oxysterols exert a pivotal role. RANTES
and MIF are cytokines with chemokine-like function and critical
mediators of the host immune and inﬂammatory response; they
are thought to act by recruiting and promoting leukocytes inﬁl-
tration to sites of inﬂammation.[61,62]
In this study, it was demonstrated that all phenolic compounds
HT, TYR, and HVA at all tested concentrations, were able to in-
hibit oxysterol-induced proinﬂammatory cytokines production in
ex vivo immune cells. According to the hypotesis that proinﬂam-
matory cytokines release may be induced by changes in intracel-
lular redox status, it was observed that, in human PBMCs treated
with the oxysterols mixture, simple phenols were able to inhibit
ROS production signiﬁcantly from the concentration of 0.5 μM
as well as to suppress redox-based MAPK phosphorylation (JNK,
p38).
In the literature there are several studies that conﬁrmed the
anti-inﬂammatory activity of olive oil phenolics in diﬀerent dis-
tricts such as in blood cells. Diﬀerential anti-inﬂammatory eﬀects
of phenolic compounds from extra virgin olive oil were identiﬁed
in human whole blood cultures: OL-glycoside and CA decreased
the concentration of IL-1β and kaempferol decreased the concen-
tration of PGE2 induced by LPS.[15]
A recent study reported similar results in macrophages where
oil phenolic extract exerted their protective eﬀects against LPS-
induced oxidative stress and inﬂammatory responses.[24,25] The
olive oil phenolic extract signiﬁcantly decreased nitric oxide (NO)
and ROS production and in addition signiﬁcant downregulated
iNOS, COX-2, reduced MAPK (JNK, p38) phosphorylation and
prevented the nuclear NF-κB traslocation.
HT inhibits iNOS and COX-2 expression in LPS-stimulated
J774 cells at the transcriptional level by preventing the activa-
tion of NF-κB, signal transducer and activator of transcription 1
(STAT-1α) and interferon regulatory factor 1 (IRF-1)[16] and TYR
prevented RAW 264.7 macrophages activation induced by gliadin
and INFγ .[63]
A recent study conducted by Palozza et al.[52] investigated the
ability of lycopene, a strong antioxidant compound present in
tomato, to prevent oxysterols induced proinﬂammatory cytokine
cascade in human macrophages. Lycopene prevented oxysterol-
induced increase in proinﬂammatory cytokines (IL-1β, IL-6,
IL-8, TNF-α) secretion and expression, such an eﬀect was ac-
companied by an inhibition of oxysterols-induced ROS produc-
tion and MAPK activation (ERK 1/2, JNK, and p38). In our
study, olive oil phenolics showed similar capabilities against
the harmful eﬀects of the oxysterols mixture in ex vivo blood
cells.
Further studies are needed to clarify the mechanism by which
the phenolic compounds exert their protective action; however,
data obtained in these experimental systems, suggested that
these compounds act primarily by counteracting the initial stages
of the prooxidant and proinﬂammatory eﬀects of oxysterols, in-
hibiting the formation of ROS and then all subsequent cascading
eﬀects.
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